Perficient Acquires BioPharm Systems
BioPharm Systems, a global IT consulting and managed services provider in the life sciences industry, has been acquired by Perficient.
BioPharm Systems, a global IT consulting and managed services provider in the life sciences industry, has been acquired by Perficient, a global IT consulting firm in many vertical markets. The acquisition of BioPharm Systems is Perficient's first in the life sciences space. According to a press release, the acquisition gives Perficient its vertical expertise in life sciences, specially in clinical trial management, clinical data management and safety and pharmacovigilance solutions; strengthens the company's Oracle-based partnerships and capabilities and adds life sciences clients including Bayer, CR Bard, Halozyme Therapeutics, Ikaria, Johnson & Johnson, Medtronic, Pfizer, St. Jude Medical, Stryker, and Sunovion. BioPharm Systems President and CEO Alex Sefanov joins the company in a key leadership role, as do 50 other professionals from the company.
Read the full release here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Pfizer Reports Strong Phase III Results for Hympavzi in Hemophilia Patients with Inhibitors
June 26th 2025The Phase III BASIS trial found that once-weekly subcutaneous Hympavzi reduced treated bleed rates by 93% in patients with hemophilia A or B with inhibitors, offering a promising new prophylactic option for a population with limited therapeutic choices.
